Article
The Economics of Pharmacogenomics.
2003-12-01
Abstract excerpt
One major driver of the uptake of pharmacogenomics will be its economic impact on overall health care costs. Given rising health care expenditures and limited health care budgets, pharmacogenomic strategies will be subject to the same scrutiny on their economic impact as other health care technologies. This review examines the economic factors relevant to key U.S. stakeholders applying pharmacogenomic strategies t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9e8098ee-5a8f-55d4-b11a-cbf05aeeeb7c
- DOI
- 10.2174/1570160033476197